| Literature DB >> 32635901 |
Lore Dewanckele1, Jeyamalar Jeyanathan1, Bruno Vlaeminck1,2, Veerle Fievez3.
Abstract
BACKGROUND: Bacteria involved in ruminal formation of trans-10 intermediates are unclear. Therefore, this study aimed at identifying rumen bacteria that produce trans-10 intermediates from 18-carbon unsaturated fatty acids. r> RESULTS: Pure cultures of 28 rumen bacterial species were incubated individually in the presence of 40 μg/mL 18:3n-3, 18:2n-6 or trans-11 18:1 under control or lactate-enriched (200 mM Na lactate) conditions for 24 h. Of the 28 strains, Cutibacterium acnes (formerly Propionibacterium acnes) was the only bacterium found to produce trans-10 intermediates from 18:3n-3 and 18:2n-6, irrespective of the growth condition. To further assess the potential importance of this species in the trans-11 to trans-10 shift, different biomass ratios of Butyrivibrio fibrisolvens (as a trans-11 producer) and C. acnes were incubated in different growth media (control, low pH and 22:6n-3 enriched media) containing 40 μg/mL 18:2n-6. Under control conditions, a trans-10 shift, defined in the current study as trans-10/trans-11 ≥ 0.9, occurred when the biomass of C. acnes represented between 90 and 98% of the inoculum. A low pH or addition of 22:6n-3 inhibited cis-9, trans-11 CLA and trans-10, cis-12 CLA formation by B. fibrisolvens and C. acnes, respectively, whereby C. acnes seemed to be more tolerant. This resulted in a decreased biomass of C. acnes required at inoculation to induce a trans-10 shift to 50% (low pH) and 90% (22:6n-3 addition). r> CONCLUSIONS: Among the bacterial species studied,C. acnes was the only bacterium that have the metabolic ability to produce trans-10 intermediates from 18:3n-3 and 18:2n-6. Nevertheless, this experiment revealed that it is unlikely that C. acnes is the only or predominant species involved in the trans-11 to trans-10 shift in vivo.Entities:
Keywords: Biohydrogenation; Cuitbacterium acnes; Pure cultures; Rumen; trans-11 to trans-10 shift
Mesh:
Substances:
Year: 2020 PMID: 32635901 PMCID: PMC7339423 DOI: 10.1186/s12866-020-01876-7
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Metabolism of 18:3n-3 and 18:2n-6a by different bacterial strains during 24 h of incubation under control growth conditions (Exp. 1). Blank cells related to 18:3n-3 and 18:2n-6 indicate no metabolism takes place by these strains
| Strain | Total VFA formed (μmol/tube; mean ± SD)b | VFA productsc | 18:3 | 18:2 | ||
|---|---|---|---|---|---|---|
| % metabolized (mean ± SD)d | Products formed (% of total intermediates formed and remaining 18:3 | % metabolized (mean ± SD)d | Products formed (% of total intermediates and remaining 18:2 | |||
| 54 ± 9.5 | A, B | |||||
| 55 ± 13.0 | A, B | |||||
| 251 ± 5.4 | A | 79.8 ± 13.94 | 10-OH ∆12,15–18:2 (45%) | 76.8 ± 6.86 | 10-OH ∆12–18:1 (62%) | |
| 210 ± 18.5 | A | 26.7 ± 14.27 | 10-OH ∆12,15–18:2 (13%) | 23.1 ± 8.56 | 10-OH ∆12–18:1 (15%) | |
| 102 ± 45.9 | B, A | 99.3 ± 0.43 | 98.0 ± 0.40 | |||
| t11 C18:1 (6%) | ||||||
| 169 ± 12.7 | B, A | 98.9 ± 0.03 | 98.4 ± 0.48 | 18:0 (76%) | ||
| 18:0 (6%) | ||||||
| t11, c15 18:2 (6%) | ||||||
| 30 ± 17.2 | A, P | |||||
| 14 ± 11.9 | A, P | |||||
| 99 ± 43.7 | P, A | 86.5 ± 15.83 | ∆11,13,15–18:3 (50%) | 88.4 ± 7.16 | ||
| 10-OH 12–18:1 (7%) | ||||||
| 24 ± 8.6 | A | |||||
| 18 ± 5.2 | A | 21.6 ± 10.58 | 13-OH ∆9,15–18:2 (6%) | 84.0 ± 2.95 | 13-OH ∆9–18:1 (69%) | |
| 16 ± 5.1 | A | 96.3 ± 1.49 | 13-OH ∆9,15–18:2 (86%) | 89.8 ± 2.99 | 13-OH ∆9–18:1 (47%) | |
| ∆9,14–18:2 (32%) | ||||||
| 147 ± 5.6 | B | |||||
| 126 ± 6.1 | B | |||||
| 121 ± 11.2 | B, A | |||||
| 191 ± 21.2 | B, P | 32.7 ± 8.92 | 13-OH ∆9,15–18:2 (19%) | 81.8 ± 3.71 | 13-OH ∆9–18:1 (63%) | |
| ∆9,14–18:2 (5%) | ||||||
| 138 ± 10.5 | B | |||||
| 134 ± 7.9 | B | |||||
| 117 ± 4.3 | B | |||||
| 125 ± 6.8 | B | |||||
| 124 ± 5.3 | B | |||||
| 120 ± 5.5 | B | |||||
| 58 ± 25.8 | A, P | |||||
| 128 ± 6.6 | B | |||||
| 63 ± 9.9 | A | 60.9 ± 11.21 | 10-OH ∆12,15–18:2 (34%) | 88.0 ± 2.20 | 13-OH ∆9–18:1 (42%) | |
| 10-OH ∆12–18:1 (24%) | ||||||
| 127 ± 3.1 | B | |||||
| 83 ± 12.0 | P, A | |||||
| 241 ± 31.8 | P, A | |||||
a The initial amount of fatty acid was 40 μg/mL
b Measured fermentation products were acetate, propionate, isobutyrate, butyrate, isovalerate, valerate and caproate
c Main VFA product: A, acetate; B, butyrate; P, propionate; in decreasing order of importance. Lactate concentration was not measured
d % metabolized, proportion of the initial 18:3n-3 or 18:2n-6 which was converted after 24 h of incubation
e Only the intermediates representing ≥5% are presented as its proportion of the sum of total intermediates and remaining initial 18:3n-3 or 18:2n-6 after 24 h of incubation
fc, cis; t, trans; CLA, conjugated linoleic acid; CLnA, conjugated linolenic acid. For each of the formed intermediates, the proportion of the respective intermediate on the sum of total produced intermediates and remainder of the initial product (i.e. 18:3n-3 or 18:2n-6) after 24 h was calculated
g The different isomers could not be separated from each other with the used technique
Influence of lactate on metabolism of 18:2n-6a by different bacterial strains during 24 h of incubation (Exp. 2)
| Strainb | Control | Lactate | SEM | |||
|---|---|---|---|---|---|---|
| % metabolizedc | Main products formed (% of total intermediates and remaining 18:2 | % metabolizedc | Main products formed (% of total intermediates and remaining 18:2 | |||
| 76.75 | 10-OH ∆12–18:1 (62%) | 82.22 | 10-OH ∆12–18:1 (67%) | 2.859 | 0.234 | |
| 23.06 | 10-OH ∆12–18:1 (15%) | 38.41 | 10-OH ∆12–18:1 (18%) | 3.716 | 0.033 | |
| 98.00 | 97.90 | 0.217 | 0.765 | |||
| 98.35 | 18:0 (69%) | 98.54 | 18:0 (76%) | 0.248 | 0.295 | |
| 88.41 | 60.79 | 20.522 | 0.395 | |||
| 10-OH 12–18:1 (7%) | 10-OH 12–18:1 (5%) | |||||
| 83.96 | 13-OH ∆9–18:1 (69%) | 80.92 | 13-OH ∆9–18:1 (64%) | 1.493 | 0.223 | |
| 89.75 | 13-OH ∆9–18:1 (47%) | 92.77 | ∆9,14–18:2 (56%) | 1.877 | 0.319 | |
| ∆9,14–18:2 (32%) | 13-OH ∆9–18:1 (27%) | |||||
| 81.82 | 13-OH ∆9–18:1 (63%) | 79.13 | 13-OH ∆9–18:1 (50%) | 2.287 | 0.452 | |
| ∆9,14–18:2 (5%) | ∆9,14–18:2 (10%) | |||||
| c9, t13, t14 18:1 (7%) | ||||||
| 88.01 | 13-OH ∆9–18:1 (42%) | 74.35 | 13-OH ∆9–18:1 (34%) | 1.786 | 0.006 | |
| 10-OH ∆12–18:1 (24%) | 10-OH ∆12–18:1 (16%) | |||||
| c9, t13, t14 18:1 (5%) | ||||||
a The initial amount of 18:2n-6 was 40 μg/mL
b Only the strains which metabolized 18:2n-6 are shown
c % metabolized, proportion of the initial 18:2n-6 which was converted after 24 h of incubation
d Only the intermediates representing ≥5% of the sum of total intermediates and remaining initial 18:2n-6 after 24 h of incubation are presented in this table
ec, cis; t, trans; CLA, conjugated linoleic acid. For each of the formed intermediates, the proportion of the respective intermediate on the sum of total produced intermediates and remainder of 18:2n-6 after 24 h was calculated
Average proportionsa (% of total intermediates and 18:2n-6) of 18:2n-6 and its biohydrogenation intermediates over a 24 h incubation period under different growth conditionsb with mono-cultures of Butyrivibrio fibrisolvens D1 or Propionibacterium acnes DSM 1897 (Exp. 3)
| SEM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Control | Low pH | DHA | Control | Low pH | DHA | Bacterium | Growth medium | Bacterium × growth medium | ||
| 18:2 | 20.72β* | 73.86α* | 71.49α* | 77.00β | 86.88α | 95.21α | 3.918 | < 0.001 | < 0.001 | < 0.001 |
| 8.01β | 25.49α* | 27.24α* | 0.54 | 0.41 | 0.54 | 3.273 | < 0.001 | 0.013 | 0.011 | |
| 71.10α* | 0.55β | 1.08β | 0.64 | 4.46 | 0.33 | 1.959 | < 0.001 | < 0.001 | < 0.001 | |
| < 0.01* | < 0.01* | 0.40 | 21.81α | 8.25β | 3.76β | 2.073 | < 0.001 | 0.001 | < 0.001 | |
a The average proportions of FA over the 24 h incubation period were computed as the area under the curve divided by the total duration of incubation (24 h), using the individual measured proportions for each FA at the different sampling times
b Low pH, control medium with pH adjusted to 5.5; DHA (docosahexaenoic acid), control medium containing 40 μg/mL of 22:6n-3; all growth media contained 40 μg/mL of 18:2n-6
c CLA, conjugated linoleic acid
α, β Means differ (P < 0.05) between growth media within the same bacterial species
* Means differ (P < 0.05) between B. fibrisolvens and C. acnes within the same growth medium
Fig. 1Effect of growth medium on the proportion of 18:2n-6 and its biohydrogenation intermediates (% of total intermediates and 18:2n-6) during a 24 h incubation period with Butyrivibrio fibrisolvens D1 (left; a–d) and Cutibacterium acnes DSM 1897 (right; e–h) (Exp. 3). The initial concentration of 18:2n-6 was 40 μg/mL. Control medium (diamond); low pH medium (square), control medium with pH adjusted to 5.5; DHA-enriched (docosahexaenoic acid) medium (triangle), control medium containing 40 μg/mL of 22:6n-3. c, cis; t, trans; CLA, conjugated linoleic acid
Average proportionsa (% of total intermediates and 18:2n-6) of 18:2n-6b and its biohydrogenation intermediates over a 24 h incubation period with different ratios of Butyrivibrio fibrisolvens D1 to Propionibacterium acnes DSM 1897 in the inoculum under control growth conditions (Exp. 4)
| SEM | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 100/0 | 50/50 | 10/90 | 2/98 | 0.4/99.6 | 0/100 | Linear | Quadratic | ||
| 18:2 | 12.35 | 19.59 | 34.90 | 49.57 | 53.30 | 66.65 | 12.928 | < 0.001 | < 0.001 |
| 19.22 | 22.44 | 10.57 | 8.89 | 4.15 | 0.02 | 7.797 | 0.013 | 0.090 | |
| 67.98 | 51.72 | 34.59 | 14.22 | 15.62 | 0.41 | 14.947 | < 0.001 | 0.035 | |
| < 0.01 | 3.03 | 11.55 | 20.08 | 19.13 | 32.92 | 3.123 | < 0.001 | 0.007 | |
| 0.45 | 3.22 | 8.39 | 7.24 | 7.80 | < 0.01 | 4.090 | 0.014 | 0.471 | |
| – | 0.08 | 0.48 | 3.00 | 4.04 | – | 4.436 | < 0.001 | < 0.001 | |
a The average proportions of FA over the 24 h incubation period were computed as the area under the curve divided by the total duration of incubation (24 h), using the individual measured proportions for each FA at the different sampling times
b The initial amount of 18:2n-6 was 40 μg/mL
c CLA, conjugated linoleic acid
d Ratio of trans-10 intermediates (trans-10, cis-12 CLA + trans-10 18:1) to trans-11 intermediates (cis-9, trans-11 CLA + trans-11 18:1)
-: The ratio is not relevant for mono-cultures as trans-11 and trans-10 are produced exclusively with mono-cultures of B. fibrisolvens and C. acnes, respectively
Fig. 2Proportion (% of total intermediates and 18:2n-6) of cis-9, trans-11 CLA + trans-11 18:1 (diamond) and trans-10, cis-12 CLA + trans-10 18:1 (square) after a 24 h incubation period in relation to the relative biomass of Cutibacterium acnes DSM 1897 in the inoculum. The initial concentration of 18:2n-6 was 40 μg/mL. a, control medium; b, low pH medium, control medium with pH adjusted to 5.5; c, DHA-enriched (docosahexaenoic acid) medium, control medium containing 40 μg/mL of 22:6n-3
Proportion (% of total intermediates and 18:2n-6) of 18:2n-6 and its biohydrogenation intermediates after 24 h of incubation under different growth conditionsa with different biomass ratios of Butyrivibrio fibrisolvens D1 to Propionibacterium acnes DSM 1897 in the inoculum (Exp. 4)
| SEM | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100/0 | 50/50 | 10/90 | 2/98 | 0.4/99.6 | 0/100 | b | Linearc | Quadraticd | |||
| 18:2 | Control | 1.81 | 2.18 | 4.76 | 25.95 | 16.44 | 46.67 | 13.050 | R*** | < 0.001 | 0.004 |
| Low pH | 53.91* | 60.34* | 53.52* | 48.95* | 51.49* | 55.24 | M*** | 0.579 | 0.320 | ||
| DHA | 13.28 | 20.29 | 38.47* | 57.28* | 64.67* | 75.28* | R × M*** | < 0.001 | 0.014 | ||
| Control | 0.20 | 18.28 | 14.75 | 7.78 | 5.03 | < 0.01 | 7.534 | R*** | < 0.001 | 0.004 | |
| Low pH | 45.51* | 17.59 | 4.03 | 0.95 | < 0.01 | < 0.01 | M*** | < 0.001 | 0.563 | ||
| DHA | 82.52* | 70.06* | 38.85* | 18.20 | 9.79 | < 0.01 | R × M*** | 0.828 | 0.043 | ||
| Control | 97.93 | 72.57 | 57.69 | 31.88 | 44.80 | 0.46 | 9.460 | R** | 0.772 | 0.977 | |
| Low pH | 0.57* | 0.38* | 0.37* | 0.44* | 0.42* | 0.39 | M*** | 0.988 | 0.990 | ||
| DHA | 4.11* | 2.15* | 2.28* | 0.74* | 2.36* | 0.36 | R × M*** | < 0.001 | 0.086 | ||
| Control | < 0.01 | 2.63 | 8.72 | 18.98 | 13.61 | 53.37 | 6.606 | R*** | < 0.001 | 0.629 | |
| Low pH | < 0.01 | 21.70* | 42.04* | 49.66* | 48.01* | 44.37 | M*** | < 0.001 | 0.767 | ||
| DHA | < 0.01 | 8.15 | 19.97 | 23.57 | 21.69 | 24.29* | R × M** | < 0.001 | 0.019 | ||
| Control | 0.06 | 4.34 | 14.08 | 15.40 | 20.11 | < 0.01 | 3.927 | R* | 0.905 | 0.943 | |
| Low pH | < 0.01 | < 0.01 | 0.04* | < 0.01* | 0.08* | < 0.01 | M*** | 0.992 | 0.998 | ||
| DHA | 0.08 | < 0.01 | 0.42* | 0.21* | 0.90* | 0.06 | R × M* | < 0.001 | 0.911 | ||
| Control | – | 0.08 | 0.34 | 2.46 | 2.44 | – | 9.296 | R*** | 0.017 | 0.082 | |
| Low pH | – | 1.22 | 12.67 | 65.74* | 90.01* | – | M*** | < 0.001 | < 0.001 | ||
| DHA | – | 0.10 | 0.95 | 2.86 | 9.74 | – | R × M** | < 0.001 | 0.003 | ||
a Low pH, control medium with pH adjusted to 5.5; DHA (docosahexaenoic acid), control medium containing 40 μg/mL of 22:6n-3; all growth media contained 40 μg/mL of 18:2n-6
b R, effect of ratio of B. fibrisolvens to C. acnes in the inoculum; M, effect of growth medium; * 0.01 ≤ P < 0.05; ** 0.001 ≤ P < 0.01; *** P < 0.001
c Linear effect of R within each growth medium
d Quadratic effect of R within each growth medium
ec9, t11 CLA, cis-9, trans-11 conjugated linoleic acid
ft10, c12 CLA, trans-10, cis-12 conjugated linoleic acid
g Ratio of trans-10 intermediates (trans-10, cis-12 CLA + trans-10 18:1) to trans-11 intermediates (cis-9, trans-11 CLA + trans-11 18:1)
* Means differ (P < 0.05) from the control growth medium within the same ratio
-: The ratio is not relevant for mono-cultures as trans-11 and trans-10 are produced exclusively with mono-cultures of B. fibrisolvens and C. acnes, respectively
Fig. 3Net production (μmol per tube) of propionic acid (diamond) and butyric acid (square) during a 24 h incubation period with different biomass ratios of Butyrivibrio fibrisolvens D1 to Cuitibacterium acnes DSM 1897 in the inoculum under control growth conditions
Provenance of the different bacterial strains used in the experiment
| No. | Family | Genus | Species | Strain | Origin | Comments | Source |
|---|---|---|---|---|---|---|---|
| 1 | Acidaminococcaceae | VR4 | Pig gut, unknowna | Type strain | DSMZ | ||
| 2 | Acidaminococcaceae | ADV 255.99 | Human peritoneal fluid, France | Type strain | DSMZ | ||
| 3 | Bifidobacteriaceae | RU 424 | Bovine rumen, unknowna | DSMZ | |||
| 4 | Bifidobacteriaceae | RU224 | Rumen, unknowna | Subsp. | DSMZ | ||
| 5 | Lachnospiraceae | D1 | Bovine rumen, unknowna | Type strain | DSMZ | ||
| 6 | Lachnospiraceae | P18 | Sheep rumen, UK | Dr. J. Wallace | |||
| 7 | Lactobacillaceae | RF1 | Bovine rumen, unknowna | Type strain | DSMZ | ||
| 8 | Lactobacillaceae | RF2 | Bovine rumen, unknowna | DSMZ | |||
| 9 | Propionibacteriaceae | DSM 1897 | Acne lesion in human facial skin, unknowna | Type strain | DSMZ | ||
| 10 | Ruminococcaceae | 7 | Bovine rumen, unknowna | Type strain | DSMZ | ||
| 11 | Streptococcaceae | Pearl 11 | Cow dung, unknowna | DSMZ | |||
| 12 | Streptococcaceae | DSM 16831 | Koala feces, Australia | Type strain | DSMZ | ||
| 13 | Veillonellaceae | B159 | Cow rumen, USA | Dr. P. Weimer | |||
| 14 | Veillonellaceae | T81 | Cow rumen, USA | Dr. P. Weimer | |||
| 15 | Veillonellaceae | LC1 | Sheep rumen, unknowna | Type strain | DSMZ | ||
| 16 | Veillonellaceae | 2602A | Cow rumen, USA | Dr. P. Weimer | |||
| 17 | Veillonellaceae | 3016B | Cow rumen, USA | Dr. P. Weimer | |||
| 18 | Veillonellaceae | 3218A | Cow rumen, USA | Dr. P. Weimer | |||
| 19 | Veillonellaceae | 3436A | Cow rumen, USA | Dr. P. Weimer | |||
| 20 | Veillonellaceae | 4251 | Cow rumen, USA | Dr. P. Weimer | |||
| 21 | Veillonellaceae | 4257 | Cow rumen, USA | Dr. P. Weimer | |||
| 22 | Veillonellaceae | 4296 | Cow rumen, USA | Dr. P. Weimer | |||
| 23 | Veillonellaceae | 4400 | Cow rumen, USA | Dr. P. Weimer | |||
| 24 | Veillonellaceae | 5045 | Cow rumen, USA | Dr. P. Weimer | |||
| 25 | Veillonellaceae | 5052B | Cow rumen, USA | Dr. P. Weimer | |||
| 26 | Veillonellaceae | 5596 | Cow rumen, USA | Dr. P. Weimer | |||
| 27 | Veillonellaceae | GA-192 | Bovine rumen, USA | Subsp. | DSMZ | ||
| 28 | Veillonellaceae | PC 18 | Bovine rumen, USA | Subsp. | DSMZ |
a Unknown, country of origin unknown
Overview of the different pure culture experiments conducted
| Bacteriuma (inoculum size, v/v) | Ratio of | Growth mediumc | Fatty acid substrated | Incubation period (h) | |
|---|---|---|---|---|---|
| Exp. 1 | 28 strains individually (Table | NA | Control | 18:3 | 24 |
| 18:2 | 24 | ||||
| 24 | |||||
| Exp. 2 | 28 strains individually (Table | NA | Lactate | 18:2 | 24 |
| Exp. 3 | 100/0 | Control | 18:2 | 0, 2, 4, 8, and 24 | |
| Low pH | 18:2 | 0, 2, 4, 8, and 24 | |||
| DHA | 18:2 | 0, 2, 4, 8, and 24 | |||
| 0/100 | Control | 18:2 | 0, 2, 4, 8, and 24 | ||
| Low pH | 18:2 | 0, 2, 4, 8, and 24 | |||
| DHA | 18:2 | 0, 2, 4, 8, and 24 | |||
| Exp. 4 | 100/0 | Control | 18:2 | 0, 4, 8, and 24 | |
| Low pH | 18:2 | 24 | |||
| DHA | 18:2 | 24 | |||
| 50/50 | Control | 18:2 | 0, 4, 8, and 24 | ||
| Low pH | 18:2 | 24 | |||
| DHA | 18:2 | 24 | |||
| 10/90 | Control | 18:2 | 0, 4, 8, and 24 | ||
| Low pH | 18:2 | 24 | |||
| DHA | 18:2 | 24 | |||
| 2/98 | Control | 18:2 | 0, 4, 8, and 24 | ||
| Low pH | 18:2 | 24 | |||
| DHA | 18:2 | 24 | |||
| 0.4/99.6 | Control | 18:2 | 0, 4, 8, and 24 | ||
| Low pH | 18:2 | 24 | |||
| DHA | 18:2 | 24 | |||
| 0/100 | Control | 18:2 | 0, 4, 8, and 24 | ||
| Low pH | 18:2 | 24 | |||
| DHA | 18:2 | 24 |
a Fresh cultures, grown in modified control medium (30% rumen fluid instead of 20%, v/v) for 12 to 36 h, depending on the growth rate of the strain (OD600 = 1.26 ± 0.41; mean ± SD), were used as inoculum
b NA, not applicable
c Lactate, control medium supplemented with 200 mM Na-lactate; low pH, control medium with pH adjusted to 5.5; DHA (docosahexaenoic acid), control medium containing 40 μg/mL of 22:6n-3
d The initial amount of fatty acid was 40 μg/mL
Fig. 4Partial GC-MS chromatogram of the C18 FAME elution profile region. t, trans; c, cis; CLA, conjugated linoleic acid; #1-#10, unidentified compounds. Different chromatograms originate from incubations with distilled water or with pure cultures of Butyrivibrio fibrisolvens D1, Cutibacterium acnes DSM 1897, Streptococcus gallolyticus DSM 16831, Streptococcus equinus Pearl 11, Megasphaera elsdenii 2602A and 5052B under control growth conditions
Fig. 5Examples of electron impact mass spectra of DMOX derivatives. a, compound #2, derived from pure culture incubation of Butyrivibrio fibrisolvens D1 under control growth conditions with 40 μg/mL 18:3n-3; b, compound #8, derived from pure culture incubation of Megasphaera elsdenii 5052B under control growth conditions with 40 μg/mL 18:2n-6